BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Ignyta To Report 2014 Second Quarter Company Highlights And Financial Results And Host Conference Call On August 12, 2014

  August 7, 2014

   · 

  1 min read
• Drug Development

  Alnylam Pharmaceuticals Receives Orphan Drug Designations In The European Union For ALN-AT3, An Rnai Therapeutic In Development For The Treatment Of Hemophilia

  August 7, 2014

   · 

  1 min read
• Business

  Bruker Corporation Reports Second Quarter 2014 Financial Results

  August 7, 2014

   · 

  1 min read
• Business

  Idera Pharmaceuticals, Inc. And The Myositis Association Join Forces To Advance The Clinical Development Of A Novel TLR Antagonist, IMO-8400, For The Treatment Of Myositis

  August 7, 2014

   · 

  1 min read
• Pharm Country

  AmerisourceBergen Corporation Declares Quarterly Dividend

  August 7, 2014

   · 

  1 min read
• Biotech Beach

  GenMark Diagnostics To Present At The Canaccord Genuity 34th Annual Growth Conference

  August 7, 2014

   · 

  1 min read
• Business

  XenoPort, Inc. Reports Second Quarter Financial Results

  August 7, 2014

   · 

  1 min read
• Genetown

  Corindus Vascular Robotics (Formerly known as Corindus) Release: Published Robotic PCI Study Reveals Favorable Results With Respect To Patient Radiation Exposure, Fluoroscopy Time, And Contrast Volume

  August 7, 2014

   · 

  1 min read
• Genetown

  Advanced Cell Technology To Host Conference Call To Provide A Corporate Update

  August 7, 2014

   · 

  1 min read
• Business

  NPS Pharmaceuticals, Inc. Reports Second-Quarter 2014 Financial Results

  August 7, 2014

   · 

  1 min read